Clinical studies recruiting near Essen

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · Universitätsklinikum Essen · AbbVie · NCT06602479 Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities
Phase 2 · Kliniken Essen-Mitte · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06722183 Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery
NA · University of Duisburg-Essen · Medical University Innsbruck · NCT05931783 Observational Study Protocol: LIVER-R
Phase N/A · AstraZeneca · NCT06252753 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Universitaetsklinikum Essen · Eli Lilly and Company · NCT07218380 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Joseph Broderick, MD · NCT07227246 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 A Clinical Study of Arfolitixorin in Patients With mCRC
Phase 1/Phase 2 · Universitaetsklinikum Essen AöR, Department of Medical Oncol · Isofol Medical AB · NCT06922383 A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Takeda · NCT06747351 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung-Klinik · Merck Sharp & Dohme LLC · NCT06393374 Giessen Stroke Registry
Phase N/A · Universitätsklinikum Gießen · University of Giessen · NCT05295862 Spinocerebellar Ataxia Type 27B Natural History Study (SCA27B-NHS)
Phase N/A · Department of Neurology & Center for Translational Neuro- an · University Hospital Tuebingen · NCT06472557 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · UKGM Gießen/Marburg · Pfizer · NCT06758401 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Universitaetsklinikum Essen · Miltenyi Biomedicine GmbH · NCT04844866 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · KEM Essen | Evang. Kliniken Essen-Mitte gGmbH · AGO Study Group · NCT05009082 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · Universitaetsklinikum Giessen und Marburg GmbH · Pfizer · NCT07073820 A Non-interventional, Prospective Study With Benralizumab
Phase N/A · Research Site · AstraZeneca · NCT06422078 PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer
Phase N/A · University Hospital Essen · University Hospital, Essen · NCT06320223 Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
NA · Universitätsklinik Essen · Ad scientiam · NCT05566769 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · KEM/Evang. Kliniken Essen Mitte gGmbH · Hoffmann-La Roche · NCT06793215 Randomization of Single vs Multiple Arterial Grafts
NA · Giessen Hospital · Weill Medical College of Cornell University · NCT03217006 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Praxis am Markt Dr. Bernd Becker · Amgen · NCT07037433 Topical Application of PRF Before Radiation Therapy
NA · University of Giessen · University of Giessen · NCT06406530 A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · Novartis Pharmaceuticals · NCT07549516 - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Misma
Phase 2 · KEM | Klinik für Internistische Onkologie gGmbH · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06856837 Endometrial Cancer Lymphadenectomy Trial
NA · Kliniken Essen Mitte, Evang. Huyssens Stiftung/Knappschaft G · Philipps University Marburg · NCT03438474 Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening
Phase N/A · University Hospital Gießen and Marburg GmbH · Heidelberg University · NCT02270476 Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
NA · Rijnstate Hospital · NCT05484115 A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
Phase 1/Phase 2 · Universitatsklinikum Essen - Neurologie · Vico Therapeutics B. V. · NCT05822908 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · Universitaetsklinikum Essen (AoR) · argenx · NCT06544499

Look up another city

Look up another condition